YVONNE CHESSER: Open Payments
NPI 1780994707 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 20 payments from 11 companies in 2025. Trend: 2023 $472 · 2024 $845 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $199 |
| Abbott Laboratories | 2 | $141 |
| Boston Scientific Corporation | 1 | $114 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Amgen Inc. | 2 | $50 |
| PFIZER INC. | 2 | $42 |
| CVRx, Inc. | 1 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| BridgeBio Pharma, Inc. | 1 | $16 |
Products named: WAINUA, AVEIR, Rhythmia Mapping System, LEQVIO, Kerendia, REPATHA, VYNDAQEL, Barostim Neo System.
Industry payments across GA — which companies pay providers there.
